$43.4 Million is the total value of HealthInvest Partners AB's 12 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UTMD | Buy | UTAH MED PRODS INC | $7,387,000 | +46.8% | 86,000 | +53.6% | 17.03% | +112.5% |
LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $4,035,000 | +33.7% | 1,265,000 | +78.9% | 9.30% | +93.5% |
HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $3,707,000 | -36.5% | 76,000 | -36.7% | 8.54% | -8.1% |
CI | Sell | CIGNA CORP NEW | $3,689,000 | -35.9% | 14,000 | -41.7% | 8.50% | -7.1% |
GILD | Sell | GILEAD SCIENCES INC | $3,585,000 | -38.5% | 58,000 | -40.8% | 8.26% | -10.9% |
BMY | Sell | BRISTOL-MYERS SQUIBB CO | $3,388,000 | -43.4% | 44,000 | -46.3% | 7.81% | -18.1% |
BIIB | Sell | BIOGEN INC | $3,263,000 | -44.7% | 16,000 | -42.9% | 7.52% | -19.9% |
MCK | Sell | MCKESSON CORP | $3,262,000 | -64.5% | 10,000 | -66.7% | 7.52% | -48.6% |
VTRS | New | VIATRIS INC | $3,246,000 | – | 310,000 | +100.0% | 7.48% | – |
KMPH | Buy | KEMPHARM INC | $2,988,000 | +132.9% | 670,000 | +162.7% | 6.89% | +237.2% |
OPNT | Buy | OPIANT PHARMACEUTICALS INC | $2,518,000 | +552.3% | 210,000 | +1066.7% | 5.80% | +843.9% |
AUPH | New | AURINIA PHARMACEUTICALS INC | $2,312,000 | – | 230,000 | +100.0% | 5.33% | – |
CAH | Exit | CARDINAL HEALTH INC | $0 | – | -100,000 | -100.0% | -9.03% | – |
IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -710,000 | -100.0% | -14.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-07-08
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
MCKESSON CORP | 14 | Q3 2022 | 14.6% |
ANTHEM INC | 12 | Q4 2017 | 14.3% |
TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-01-30 |
13F-HR | 2023-02-14 |
13F-HR | 2022-10-21 |
13F-HR | 2022-07-08 |
13F-HR | 2022-05-05 |
13F-HR | 2022-01-18 |
13F-HR | 2021-11-08 |
13F-HR | 2021-08-10 |
13F-HR | 2021-04-30 |
13F-HR | 2021-02-05 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.